![]() |
courtesy of the Willem J. Kolff Collection at the University of Utah Marriott Library |
![]() |
Courtesy of the Willem J. Kolff Collection at the University of Utah Marriott Library |
Willem Kolff with artificial heart courtesy of the Willem J. Kolff Collection at the University of Utah Marriott Library Willem Kolff, a University of Utah physician who invented the precursor to kidney dialysis and the first artificial heart, died last week a few days shy of his 98th birthday. Kolff received the 2002 Albert Lasker Award for Clinical Medical Research. He died of natural causes, the New York Times reported. The artificial heart that he helped develop "has now been used in ov
![]() |
courtesy of the Willem J. Kolff Collection at the University of Utah Marriott Library |
![]() |
Courtesy of the Willem J. Kolff Collection at the University of Utah Marriott Library |



When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.


In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.

In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.


Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.


Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST

Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.

Collaboration will bring next generation orchestration and modular automation to scientists worldwide

The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.